Outcomes of salvage autologous stem cell transplantation for multiple myeloma with cytopenias and exposure to novel agents

Bone Marrow Transplant. 2017 Oct;52(10):1468-1470. doi: 10.1038/bmt.2017.160. Epub 2017 Jul 24.

Authors

D Tremblay¹, G Lancman¹, E Moshier¹, N Bar², S Jagannath¹, A Chari¹

Affiliations

¹ Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
² Department of Internal Medicine, Section of Hematology, Yale School of Medicine, New Haven, CT, USA.

PMID: 28737774
DOI: 10.1038/bmt.2017.160

No abstract available

MeSH terms

Adult
Aged
Autografts
Female
Follow-Up Studies
Humans
Male
Melphalan / administration & dosage*
Middle Aged
Multiple Myeloma / mortality*
Multiple Myeloma / therapy*
Peripheral Blood Stem Cell Transplantation*

Substances

Melphalan